Blog
136 Articles
Cachexia Research Showing Promise
Dr. Teresa Zimmers reports on the latest developments in countering cachexia in pancreatic cancer patients.
Practical Tips For Patients In Treatment
Long-term survivor and patient advocate Steven Merlin has a host of practical tips for patients to help manage life during treatment.
Targeting a KRAS Variant in Advanced Pancreatic Cancer
Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.
Chemo Before Surgery Doubles Overall Survival in Some Patients
Dr. Marco Del Chiaro explains the results of an international study of outcomes for patients who had neoadjuvant treatment before surgery.
Testing a New Chemo and RNA Therapy Combination
Researchers are testing a new drug that binds to messenger RNA in combination with mFOLFIRINOX chemotherapy.
Pancreatic Cancer Research Updates from ASCO 2024
Learn about the latest developments in pancreatic cancer research into immunotherapy and chemotherapy from the ASCO 2024 meeting.
No Time To Lose
Eduardo Servin acted pretty quickly when he began itching all over and noticed that he was jaundiced. He believes this saved his life.
The Sound of Hope
Kim Bate has a long family history of pancreatic cancer, losing his sister and twin brother to it. Then he received the same diagnosis.
What to Eat—and What to Avoid—When You Have Pancreatic Cancer
The disease and treatment for pancreatic cancer affect the digestive system. Dietitian L.J. Amaral guides you to the best nutrition sources.
How Far I’ve Come
After Whipple surgery, chemo, and another emergency, long-term survivor Monsita Botwick needed help from a therapist to continue treatment.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
Cancer-Free and Running Strong
After her Whipple procedure, Janice Canfield is making the most of her time, working, running races, and traveling the world.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.